Clinical trial
fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With…
NCT00332046 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00332046 |
|---|---|
| Title | fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder |
| Official title | A Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Parallel Group, fMRI Study Comparing BOLD Activation Patterns Before and After 12 Weeks of Treatment With Placebo, Comparator and GW679769 in Subjects With Social Anxiety Disorder (SAD). |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Social Anxiety Disorder |
| Intervention type | Drug |
| Interventions | GW679769 |
| Enrollment | 57 |
| Start date | Jan 1, 2006 |
| First posted | Jun 1, 2006 |
| Last update posted | Oct 16, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: